Schwarting Recorded Webinars

Recorded webinars are available below....

Patient Safety: Drug Induced Cardiovascular Disease – 2021 – COMING SOON

Patient Safety: Drug Induced Cardiovascular Disease -Presentation   This may take a few seconds to download to your computer

Handouts
Quiz-Pharmacist
Register

In this application-based continuing pharmacy immunization education activity Mike White,PharmD, FCCP, FCP, discusses the way drugs can induce CVD.

Target Audience:

Pharmacists interested in CVD and involved in patient care.

Learning objectives:

At the conclusion of the activity, pharmacists will be able to:

  • Identify heart block.
  • Differentiate between 1st, type-1 2nd, type-2 2nd, and 3rd degree AV block
  • Describe the drugs and dietary supplements that can cause heart block and what to do if drug induced hear block occurs acutely and chronically
  • Identify QTc interval prolongation and describe how much of an elevation dramatically enhances the risk of Torsade de Pointes
  • Describe drugs and dietary supplements that may prolong QTc interval and interventions for acute Torsade de Pointes or chronic QTc interval prolongation
  • Apply knowledge to a relevant patient case.

Activity Faculty

C. Michael White, PharmD, FCCP, FCP, BOT
Distinguished Professor and Chair of Pharmacy Practice
University of Connecticut School of Pharmacy
Storrs, CT

Faculty Disclosure:

In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.

  • C. Michael White has no disclosures

Program Fees:

Click on the registration link to register for this activity. The cost is $15.00.

Grant Funding:

This activity has no grant funding associated with it.

The University of Connecticut, School of Pharmacy, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.0 contact hour (0.1 CEU) will be awarded to pharmacists who view the presentation, pass the learning assessment with a grade of 70% or better and complete an evaluation. (ACPE #0009-0000-21-007-H05-P) Credits will  be electronically submitted to CPE Monitor within 72 hours of completing the activity.

Initial release date: May 13, 2021
Planned expiration date: D 13, 2024

Disclaimer
The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

Patient Safety: Psychosis as the Diagnosis, Drugs as the Cause-2021 – COMING SOON

Patient Safety: Psychosis as the Diagnosis, Drugs as the Cause - Presentation   This may take a few seconds to download to your computer-

Handouts
Quiz
Register

In this application-based continuing pharmacy education activity Kristin Waters, PharmD, BCPPS, BCPS, discusses the pyschosis that can be caused by medications unrelated to psychiatric treatment.

Target Audience:

All pharmacists interested in drug interactions that may have patient interaction.

Learning objectives:

At the conclusion of this activity, pharmacists will be able to:

  1. Identify features of drug-induced psychosis and differentiate between drug-induced psychosis vs. psychosis associated with a medical or mental illness
  2. Articulate which substances are most likely to contribute to psychotic symptoms, including prescription medications, over-the-counter medications, and illicit substances
  3. Apply knowledge of drug-induced psychosis to patient case examples

Activity Faculty

Kristin Waters, PharmD, BCPPS, BCPS

University of Connecticut School of Pharmacy
Storrs, CT  

Faculty Disclosure:

In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.

  • Kristin Waters, PharmD, BCPPS, BCPS has no disclosures

Program Fees:

Click on the registration link to register for this activity. The cost is $15.00.

Grant Funding:

This activity has no grant funding associated with it.

ACPE logoThe University of Connecticut, School of Pharmacy, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.0 contact hour (0.1 CEU) will be awarded to pharmacists who view the presentation, pass the learning assessment with a grade of 70% or better and complete an evaluation. (ACPE #0009-0000-21-008-H05-P) Credits will  be electronically submitted to CPE Monitor within 72 hours of completing the activity.

Initial release date: May 13, 2021
Planned expiration date: May 13, 2024

Disclaimer
The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

Patient Safety: Medication-Induced Hyperglycemia and Diabetes 2021 – COMING SOON

Patient Safety: Medication-Induced Hyperglycemia and Diabetes -Presentation  This may take a few seconds to download to your computer-

Handouts
Quiz
Register

In this knowledge-based continuing pharmacy education activity Devra Dang, PharmD., BCPS, CDE, FNAP, discusses medication side effects that can present as DM.

Target Audience:

Pharmacists interested in medication side effects especially in the treatment of diabetes.

Learning objectives:

At the conclusion of this activity pharmacists will be able to:

  • List major causative medications leading to hyperglycemia and diabetes mellitus and their putative mechanisms
  • Describe clinical manifestations of medication-induced hyperglycemia
    Identify preventive and management strategies for medication-induced hyperglycemia

Activity Faculty

Devra Dang, PharmD., BCPS, CDE, FNAP
Associate Clinical Professor
University of Connecticut School of Pharmacy
Storrs, CT

Faculty Disclosure:

In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.

  • Devra Dang has no disclosures

Program Fees:

Click on the registration link to register for this activity. The cost is $15.00.

Grant Funding:

This activity has no grant funding associated with it.

ACPE logoThe University of Connecticut, School of Pharmacy, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.0 contact hour (0.1 CEU) will be awarded to pharmacists who view the presentation, pass the learning assessment with a grade of 70% or better and complete an evaluation. (ACPE #0009-0000-20-009-H05-P Credits will  be electronically submitted to CPE Monitor within 72 hours of completing the activity.

Initial release date: May 13, 2021
Planned expiration date: May 13, 2024

Disclaimer
The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

Patient Safety: Secondary Cancers: What the Pharmacist Needs to Know – 2021 – C’OMING SOON

Patient Safety:  Secondary Cancers: What the Pharmacist Needs to Know-Presentation  This may take a few seconds to download to your computer

Handouts
Quiz
Register

In this application-based continuing pharmacy education activity Lisa Holle, discusses secondary cancers.

Target Audience:

Pharmacists interested in oncology or potential drug side effects.

Learning objectives:

At the conclusion of this activity, pharmacists will be able to:

Identify risk factors for developing secondary cancers
Differentiate treatment options for secondary cancers from those of primary cancers at the same site
Demonstrate pharmacist-driven interventions to reduce risk of, screen for, and optimally manage secondary cancers

Faculty Disclosure:

In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.

  • Lisa Holle has no disclosures

Program Fees:

Click on the registration link to register for this activity. The cost is $15.00.

Grant Funding:

This activity has no grant funding associated with it.

The University of Connecticut, School of Pharmacy, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.0 contact hour (0.1 CEU) will be awarded to pharmacists who view the presentation, pass the learning assessment with a grade of 70% or better and complete an evaluation. (ACPE #0009-0000-21-010-H05-P) Credits will  be electronically submitted to CPE Monitor within 72 hours of completing the activity.

Initial release date: May 13, 2021
Planned expiration date: May 13, 2024

Disclaimer
The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.